Orgenesis Other Operating Expenses from 2010 to 2024
| ORGS Stock | USD 0.55 0.02 3.77% |
Other Operating Expenses | First Reported 2009-02-28 | Previous Quarter 2.2 M | Current Value 32.5 M | Quarterly Volatility 9.4 M |
Check Orgenesis financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Orgenesis main balance sheet or income statement drivers, such as Interest Expense of 0.0, Gross Profit of 599.5 K or Other Operating Expenses of 216.6 K, as well as many exotic indicators such as Price To Sales Ratio of 28.77, Dividend Yield of 0.0 or Days Sales Outstanding of 1.9 K. Orgenesis financial statements analysis is a perfect complement when working with Orgenesis Valuation or Volatility modules.
Orgenesis | Other Operating Expenses |
Latest Orgenesis' Other Operating Expenses Growth Pattern
Below is the plot of the Other Operating Expenses of Orgenesis over the last few years. Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Orgenesis. It is also known as Orgenesis overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. It is expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production. Orgenesis' Other Operating Expenses historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Orgenesis' overall financial position and show how it may be relating to other accounts over time.
| Other Operating Expenses | 10 Years Trend |
|
Other Operating Expenses |
| Timeline |
Orgenesis Other Operating Expenses Regression Statistics
| Arithmetic Mean | 23,359,719 | |
| Geometric Mean | 4,568,368 | |
| Coefficient Of Variation | 125.38 | |
| Mean Deviation | 22,430,187 | |
| Median | 10,185,000 | |
| Standard Deviation | 29,287,795 | |
| Sample Variance | 857.8T | |
| Range | 103.4M | |
| R-Value | 0.35 | |
| Mean Square Error | 808.7T | |
| R-Squared | 0.12 | |
| Significance | 0.20 | |
| Slope | 2,311,576 | |
| Total Sum of Squares | 12008.8T |
Orgenesis Other Operating Expenses History
About Orgenesis Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Orgenesis income statement, its balance sheet, and the statement of cash flows. Orgenesis investors use historical funamental indicators, such as Orgenesis's Other Operating Expenses, to determine how well the company is positioned to perform in the future. Although Orgenesis investors may use each financial statement separately, they are all related. The changes in Orgenesis's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Orgenesis's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Orgenesis Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Orgenesis. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Other Operating Expenses | 228 K | 216.6 K |
Pair Trading with Orgenesis
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Orgenesis position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Orgenesis will appreciate offsetting losses from the drop in the long position's value.Moving against Orgenesis Stock
| 0.54 | MRK | Merck Company Earnings Call This Week | PairCorr |
| 0.45 | SNDL | SNDL Inc | PairCorr |
The ability to find closely correlated positions to Orgenesis could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Orgenesis when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Orgenesis - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Orgenesis to buy it.
The correlation of Orgenesis is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Orgenesis moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Orgenesis moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Orgenesis can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of Orgenesis Correlation against competitors. For more information on how to buy Orgenesis Stock please use our How to Invest in Orgenesis guide.Note that the Orgenesis information on this page should be used as a complementary analysis to other Orgenesis' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Complementary Tools for Orgenesis Stock analysis
When running Orgenesis' price analysis, check to measure Orgenesis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Orgenesis is operating at the current time. Most of Orgenesis' value examination focuses on studying past and present price action to predict the probability of Orgenesis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Orgenesis' price. Additionally, you may evaluate how the addition of Orgenesis to your portfolios can decrease your overall portfolio volatility.
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Money Managers Screen money managers from public funds and ETFs managed around the world |
Is Orgenesis' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Orgenesis. If investors know Orgenesis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Orgenesis listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.77) | Revenue Per Share 0.017 | Quarterly Revenue Growth (0.98) | Return On Assets (0.42) | Return On Equity (3.25) |
The market value of Orgenesis is measured differently than its book value, which is the value of Orgenesis that is recorded on the company's balance sheet. Investors also form their own opinion of Orgenesis' value that differs from its market value or its book value, called intrinsic value, which is Orgenesis' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Orgenesis' market value can be influenced by many factors that don't directly affect Orgenesis' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Orgenesis' value and its price as these two are different measures arrived at by different means. Investors typically determine if Orgenesis is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Orgenesis' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.